Treatment choice for localized prostate cancer depends on cancer aggressiveness and quality-of-life factors, such as sexual functioning. Active surveillance is a safe option for appropriate patients, ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone ...